Association of estrogen receptor α gene with Alzheimer's disease:: A case-control study

被引:0
|
作者
Monastero, Roberto
Cefalu, Angelo B.
Camarda, Cecilia
Noto, Davide
Camarda, Lawrence K.
Caldarella, Rosalia
Imbornone, Emilia
Averna, Maurizio R.
Camarda, Rosolino
机构
[1] Univ Palermo, DiNOOP, LEPAD, Sez Neurol & Psichiat, I-90129 Palermo, Italy
[2] Univ Palermo, Dept Internal Med, Palermo, Italy
关键词
Alzheimer's disease; estrogen receptor alpha gene; apolipoprotein E; case-control study; polymorphism;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent experimental data have offered the biological background to study the estrogen receptor (ER) a gene as a candidate gene for AD. Genetic association studies proposed ER alpha PvuII and XbaI gene polymorphisms as susceptibility factors for AD, although subsequent studies did not replicate this finding. To verify this association in a Caucasian Italian sample, we conducted a case-control study in a dataset of 172 clinic-based probable AD cases and 172 age- and sex-matched controls. Possible interaction between ER alpha polymorphisms and sex, age at onset of AD or apolipoprotein E (APOE) was examined. The xx-genotype of the XbaI polymorphism was associated with the risk of developing AD in the total sample (OR 1.9, 95% CI [1.2-3.1]). The risk increased in women (OR 2.3, 95% CI [1.3-4.2]), and in subjects with late-onset AD (OR 2.1, 95% CI [1.2-3.5]). PvuII polymorphism did not contribute to the risk of AD. There was no evidence for a statistical interaction between the APOE and either the PvuII and XbaI polymorphisms. This result shows that ERa XbaI polymorphism is an additional risk factor for women with late-onset AD.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [31] Oral health in Alzheimer's disease: a multicenter case-control study
    Aragon, F.
    Zea-Sevilla, M. A.
    Montero, J.
    Sancho, P.
    Corral, R.
    Tejedor, C.
    Frades-Payo, B.
    Paredes-Gallardo, V.
    Albaladejo, A.
    CLINICAL ORAL INVESTIGATIONS, 2018, 22 (09) : 3061 - 3070
  • [32] Oral health in Alzheimer’s disease: a multicenter case-control study
    F. Aragón
    M. A. Zea-Sevilla
    J. Montero
    P. Sancho
    R. Corral
    C. Tejedor
    B. Frades-Payo
    V. Paredes-Gallardo
    A. Albaladejo
    Clinical Oral Investigations, 2018, 22 : 3061 - 3070
  • [33] Benzodiazepine use and risk of Alzheimer's disease: case-control study
    de Gage, Sophie Billioti
    Moride, Yola
    Ducruet, Thierry
    Kurth, Tobias
    Verdoux, Helene
    Tournier, Marie
    Pariente, Antoine
    Begaud, Bernard
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [34] Blood pressure dysregulation and Alzheimer's disease: a case-control study
    Sobow, T
    Kloszewska, I
    EUROPEAN PSYCHIATRY, 2002, 17 : 132S - 132S
  • [35] Suicide in the elderly and Alzheimer's disease: A case-control study.
    Rubio, A
    Vestner, AL
    Stewart, J
    Forbes, N
    Conwell, Y
    Cox, C
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 471 - 471
  • [36] A case-control study of the locus coeruleus degeneration in Alzheimer's disease
    Hou, Ruihua
    Beardmore, Rebecca
    Holmes, Clive
    Osmond, Clive
    Darekar, Angela
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 43 : 153 - 159
  • [37] Estrogen receptor alpha gene polymorphism and endometrial cancer risk – a case-control study
    Sara Wedrén
    Lovisa Lovmar
    Keith Humphreys
    Cecilia Magnusson
    Håkan Melhus
    Ann-Christine Syvänen
    Andreas Kindmark
    Ulf Landegren
    Maria Lagerström Fermér
    Fredrik Stiger
    Ingemar Persson
    John A Baron
    Elisabete Weiderpass
    BMC Cancer, 8
  • [38] Estrogen receptor alpha gene polymorphism and endometrial cancer risk - a case-control study
    Wedren, Sara
    Lovmar, Lovisa
    Humphreys, Keith
    Magnusson, Cecilia
    Melhus, Hakan
    Syvanen, Ann-Christine
    Kindmark, Andreas
    Landegren, Ulf
    Fermer, Maria Lagerstrom
    Stiger, Fredrik
    Persson, Ingemar
    Baron, John A.
    Weiderpass, Elisabete
    BMC CANCER, 2008, 8 (1)
  • [39] Lack of an association of estrogen receptor α gene polymorphisms and transcriptional activity with Alzheimer disease
    Maruyama, H
    Toji, H
    Harrington, CR
    Sasaki, K
    Izumi, Y
    Ohnuma, T
    Arai, H
    Yasuda, M
    Tanaka, C
    Emson, PC
    Nakamura, S
    Kawakami, H
    ARCHIVES OF NEUROLOGY, 2000, 57 (02) : 236 - 240
  • [40] Apolipoprotein E in Alzheimer's disease risk and case detection: A case-control study
    Kukull, WA
    Schellenberg, GD
    Bowen, JD
    McCormick, WC
    Yu, CE
    Teri, L
    Thomson, JD
    OMeara, ES
    Larson, EB
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (10) : 1143 - 1148